Is there reimbursement for Changde lung cancer targeted drug?
Based on the information provided so far, it was impossible to determine whether Changde's targeted lung cancer drug was eligible for reimbursement. Read more exciting novels for free
Is an 85-year-old man's late-stage lung cancer targeted drug effective?
Advanced lung cancer could be treated with targeted therapy, which was a very important method in the treatment of lung cancer. However, targeted therapy required a specific target. It was a precise treatment method. The appropriate targeted drug had to be selected according to the different pathological types of lung cancer and the different gene mutation characteristics. For an 85-year-old patient with advanced lung cancer, if there was a suitable target, the targeted drug was effective. For example, in patients with lung cancer with advanced egfr-mutation, the effective rate of oral egfr-small-molecular Tyrosin Kinase Inhibition targeted drugs could reach 70%. The efficacy was better than chemotherapy and the side effects were significantly lower than chemotherapy. Most patients could tolerate it, even in elderly patients. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What targeted drug is the best and most effective treatment for lung cancer with hepatic distension?
The targeted treatment of lung cancer with cardiac metastasies could use common drugs such as erlotini and gefitini, but there was no absolute "best and most effective" targeted drug. Target therapy was a precise attack by identifying specific protein molecules on cancer cells. It was suitable for lung cancer patients with corresponding targets and could reduce normal tissue damage. Different patients may have different reactions to targeted drugs due to individual differences (such as gene type, physical tolerance, etc.). For example, some patients might respond better to erlotini, while others might be more suitable for other targeted drugs such as gefitini. In actual treatment, doctors would combine various factors to develop the most suitable treatment plan for the patient. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is the targeted drug for liver cancer metastasizing useful?
If liver cancer patients had metastasized, they could use targeted drugs, but they had to pay attention to their own condition. For patients with liver cancer lung metastasizing, they could take targeted drugs such as sorafenib, gefitini, or afatini. Sorafenib was more commonly used to treat untreatable or distant cancerous tumors. However, if there was severe liver function decline, large amounts of ascitic fluid, digestive tract bleeding, hepatic epilepsy, repeated infection, and other conditions, it was not suitable to use targeted drugs. At the same time, although targeted drugs had a certain effect on many liver cancer patients, some patients had no effect at all, and the cost was relatively high. Therefore, it was necessary to choose according to the individual's actual situation. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is there an imitation of the targeted drug for cervical cancer in India?
Yes, there was an Indian imitation version of the targeted drug. For example, there was an Indian version of Niraparini, but its price was difficult for ordinary family patients to afford. A box of Indian version of Niraparini cost about 20000 yuan. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it always effective to take targeted drugs for lung cancer?
The effect of targeted drugs on lung cancer patients was not very good. Target drugs could not cure lung cancer. Although they could prolong survival time, they could not always be effective. There were very few driver mutations in lung cancer, so there were relatively few targeted drugs that could be used. When using targeted drugs, it was necessary to find the target of lung cancer and could not be used blindly. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
How long will it take for targeted drugs to be effective for lung cancer?
Patients with lung cancer usually took targeted drugs for ten days, no more than forty days, and the effect would take effect in two to three days. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
How long do you take targeted drugs for lung cancer?
The time taken for targeted treatment of lung cancer needed to be considered from both the patient's own condition and the progression of the disease. For patients with middle-stage lung cancer, it is recommended to take the first-generation targeted drug for 1.5 - 2 years or the third-generation targeted drug for 3 years. For patients with advanced lung cancer, as long as the targeted drug was effective, it was recommended to take it until the disease progressed. If drug resistance appeared, the targeted drug would need to be replaced. However, it should be noted that the premise of using targeted drugs was that the patient must have a clear target for treatment in the body, and there must be a specific drug targeting the target before targeted drug therapy could be carried out. Less than 20% of lung cancer patients could find targeted drugs. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What is the survival rate of targeted drugs in the treatment of advanced lung cancer?
There was a large individual difference in the survival rate of patients with advanced lung cancer after taking targeted drugs. The time from the start of treatment to disease progression or death was 9.2 - 18.9 months, and the general overall survival period was 21.6 - 36 months. Some studies had shown that the average survival time for late-stage lung cancer patients with targeted drugs was about three years, but there were also cases where it was as short as one or two years and as long as ten years. According to the data, after comprehensive treatment, the 2-year survival rate of stage IUA lung cancer patients was 23%, the 5-year survival rate was 10%, and the medium survival time was 11.5 months. For stage IUA lung cancer patients who had multiple metastasies, the 2-year survival rate was 10%, and the medium survival time was 6 months. In addition, in some studies, the 1-year, 2-year, 3-year, 4-year, and 5-year overall survival rates of the control group (first-line therapy with a combination of a combination The patient's physical condition, the effect of the targeted therapy, whether the attitude was positive, the degree of cooperation with the treatment, whether the patient had underlying diseases, and the support, care, and financial investment of the family would all affect the survival rate. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Does lung cancer have targeted drugs that need to be taken all the time?
Whether or not targeted drugs for lung cancer needed to be taken all the time could not be said to be the same. On the one hand, targeted drugs may face the problem of drug resistance in cancer cells during treatment. Due to the rapid evolution of cancer cells, new genetic mutations may occur during the targeted drug treatment to avoid the targeted drug attack, resulting in drug resistance in the body. Once this happens, the targeted drug may not be able to continue to effectively suppress tumor growth. At this time, it may be necessary to change the treatment plan, such as switching to other targeted drugs or changing to chemotherapy. On the other hand, if the patient had a good response to the targeted drug and did not have any serious adverse reactions or drug resistance, from the perspective of continuous suppression of tumor cell growth and prevention of cancer relapse and migration, it might be necessary to continue taking the targeted drug to maintain the treatment effect. At the same time, factors such as the patient's actual disease progression and overall physical condition would also affect the duration of the targeted drug's use. The specifics should be determined according to the diagnosis of a professional doctor. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is the lung tumor lung cancer?
A lung tumor might not be lung cancer. Lung tumors included benign and malignant tumors. Among them, malignant tumors included lung cancer, which had the highest mortality rate among lung malignant tumors. However, lung tumors could also be benign tumors, such as hamartomas, chondriomas, and tumors. They could also be lung metastasies formed by malignant tumors of other organs and tissues migrating to the lungs. The novel " Ten Years of Death " is equally exciting. Everyone is welcome to click and read it!